pharmacie et médicaments – Sous-déclaration des aides publiques à la recherche pharmaceutique

This written question asks about the under-reporting of public aid for pharmaceutical research. It seeks clarification on how such aid is declared and accounted for, potentially impacting transparency and fair competition within the sector. The question affects pharmaceutical companies, research institutions, and public funding bodies. It raises concerns about the accurate assessment of state aid and its potential distortion of the market for medicines.